Glatopa Approval History
Glatopa (glatiramer acetate) is a generic version of Copaxone, an immunomodulator drug for the treatment of patients with relapsing-forms of multiple sclerosis.
Development History and FDA Approval Process for Glatopa
|Apr 16, 2015||FDA Approves Glatopa (glatiramer acetate) as the First Generic Competitor to Copaxone|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.